Article Search
검색
검색 팝업 닫기

Metrics

Help

  • 1. Aims and Scope

    Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE

  • 2. Editorial Board

    Editor-in-Chief + MORE

    Editor-in-Chief
    Yong Chan Lee Professor of Medicine
    Director, Gastrointestinal Research Laboratory
    Veterans Affairs Medical Center, Univ. California San Francisco
    San Francisco, USA

    Deputy Editor

    Deputy Editor
    Jong Pil Im Seoul National University College of Medicine, Seoul, Korea
    Robert S. Bresalier University of Texas M. D. Anderson Cancer Center, Houston, USA
    Steven H. Itzkowitz Mount Sinai Medical Center, NY, USA
  • 3. Editorial Office
  • 4. Articles
  • 5. Instructions for Authors
  • 6. File Download (PDF version)
  • 7. Ethical Standards
  • 8. Peer Review

    All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
    The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.

    The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.

Search

Search

Year

to

Article Type

Corrigendum

Split Viewer

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Jung Rock Moon1, Chang Kyun Lee1, Sung Noh Hong2, Jong Pil Im3, Byong Duk Ye4, Jae Myung Cha5, Sung-Ae Jung6, Kang-Moon Lee7, Dong Il Park8, Yoon Tae Jeen9, Young Sook Park10, Jae Hee Cheon11, Hyesung Kim12, BoJeong Seo12, Youngdoe Kim12, Hyo Jong Kim1, the MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID)

1Center for Crohn’s and Colitis, Department of Gastroenterology, Kyung Hee University College of Medicine, 2Department of Medicine, Sungkyunkwan University School of Medicine, 3Department of Internal Medicine, Seoul National University College of Medicine, 4Department of Gastroenterology, University of Ulsan College of Medicine, 5Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, 6Department of Internal Medicine, Ewha Womans University College of Medicine, 7Department of Internal Medicine, College of Medicine, The Catholic University of Korea, 8Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 9Department of Gastroenterology and Hepatology, Korea University College of Medicine, 10Department of Internal Medicine, Eulji University School of Medicine, 11Department of Internal Medicine, Yonsei University College of Medicine, and 12Medical Affairs, Janssen Korea, Seoul, Korea

Gut Liver 2021;15(1):146-147. https://doi.org/10.5009/gnl15011

Published online January 15, 2021, Published date January 15, 2021

Copyright © Gut and Liver.

https://doi.org/10.5009/gnl19107

Gut Liver 2020;14(4):459-467

In the version of this article initially published, Table 2 contains an error in the data of p-value.

On page 462, the table should be corrected as follows (marked in bold):

From:

Mean Values of Each Patient-Reported Outcome Measure

PROs Category No. Overall (n=355) Disease severity p-value

Moderate (n=330)* Severe (n=25)
HADS Depression 349 6.6±4.5 6.5±4.4 8.9±5.2 0.610
Anxiety 348 6.2±4.4 6.2±4.4 6.6±4.5 0.638
WPAI:UC Absenteeism 149 29.1±36.9 27.3±35.8 54.1±43.5 0.102
Presenteeism§ 143 37.8±31.4 36.8±30.3 62.2±39.6 0.037
Overall work impairmentII 130 45.5±32.7 44.1±31.9 70.7±37.8 0.048
Social activity impairment 344 46.4±31.2 45.2±31.0 61.2±31.0 0.014
IBDQ Bowel system 344 41.7±13.0 42.0±13.1 36.1±10.9 0.027
Emotional health 347 51.7±14.9 52.0±14.9 46.8±13.6 0.097
Systemic symptoms 347 20.5±6.8 20.7±6.8 17.0±6.0 0.009
Social function 309 23.2±7.7 22.8±7.9 18.0±6.8 0.003
Total score 305 137.3±38.8 137.5±39.0 117.9±33.2 0.002

Data are presented as the mean±SD.

PRO, patient-reported outcome; HADS, Hospital Anxiety and Depression Scale; WPAI, Work Productivity and Activity Impairment; UC, ulcerative colitis; IBDQ, Inflammatory Bowel Disease Questionnaire.

*Total Mayo score 6–10 points; Total Mayo score ≥11; Absenteeism: percentage of work time missed=(Q2/[Q2+Q4])×100; §Presenteeism: percentage of impairment while working=(Q5/10)×100; IIPercentage of overall work impairment=(Q2/(Q2+Q4)+[(1–(Q2/(Q2+Q4)))×(Q5/10)])×100; Percentage of social activity impairment=(Q6/10)×100; Q, questionnaire item.


To:

Mean Values of Each Patient-Reported Outcome Measure

PROs Category No. Overall (n=355) Disease severity p-value

Moderate (n=330)* Severe (n=25)
HADS Depression 349 6.6±4.5 6.5±4.4 8.9±5.2 0.024
Anxiety 348 6.2±4.4 6.2±4.4 6.6±4.5 0.638
WPAI:UC Absenteeism 149 29.1±36.9 27.3±35.8 54.1±43.5 0.102
Presenteeism§ 143 37.8±31.4 36.8±30.3 62.2±39.6 0.037
Overall work impairmentII 130 45.5±32.7 44.1±31.9 70.7±37.8 0.048
Social activity impairment 344 46.4±31.2 45.2±31.0 61.2±31.0 0.014
IBDQ Bowel system 344 41.7±13.0 42.0±13.1 36.1±10.9 0.027
Emotional health 347 51.7±14.9 52.0±14.9 46.8±13.6 0.097
Systemic symptoms 347 20.5±6.8 20.7±6.8 17.0±6.0 0.009
Social function 309 23.2±7.7 22.8±7.9 18.0±6.8 0.003
Total score 305 137.3±38.8 137.5±39.0 117.9±33.2 0.002

Data are presented as the mean±SD.

PRO, patient-reported outcome; HADS, Hospital Anxiety and Depression Scale; WPAI, Work Productivity and Activity Impairment; UC, ulcerative colitis; IBDQ, Inflammatory Bowel Disease Questionnaire.

*Total Mayo score 6–10 points; Total Mayo score ≥11; Absenteeism: percentage of work time missed=(Q2/[Q2+Q4])×100; §Presenteeism: percentage of impairment while working=(Q5/10)×100; IIPercentage of overall work impairment=(Q2/(Q2+Q4)+[(1–(Q2/(Q2+Q4)))×(Q5/10)])×100; Percentage of social activity impairment=(Q6/10)×100; Q, questionnaire item.



Article

Corrigendum

Gut and Liver 2021; 15(1): 146-147

Published online January 15, 2021 https://doi.org/10.5009/gnl15011

Copyright © Gut and Liver.

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Jung Rock Moon1, Chang Kyun Lee1, Sung Noh Hong2, Jong Pil Im3, Byong Duk Ye4, Jae Myung Cha5, Sung-Ae Jung6, Kang-Moon Lee7, Dong Il Park8, Yoon Tae Jeen9, Young Sook Park10, Jae Hee Cheon11, Hyesung Kim12, BoJeong Seo12, Youngdoe Kim12, Hyo Jong Kim1, the MOSAIK study group of the Korean Association for the Study of Intestinal Diseases (KASID)

1Center for Crohn’s and Colitis, Department of Gastroenterology, Kyung Hee University College of Medicine, 2Department of Medicine, Sungkyunkwan University School of Medicine, 3Department of Internal Medicine, Seoul National University College of Medicine, 4Department of Gastroenterology, University of Ulsan College of Medicine, 5Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, 6Department of Internal Medicine, Ewha Womans University College of Medicine, 7Department of Internal Medicine, College of Medicine, The Catholic University of Korea, 8Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 9Department of Gastroenterology and Hepatology, Korea University College of Medicine, 10Department of Internal Medicine, Eulji University School of Medicine, 11Department of Internal Medicine, Yonsei University College of Medicine, and 12Medical Affairs, Janssen Korea, Seoul, Korea

Body

https://doi.org/10.5009/gnl19107

Gut Liver 2020;14(4):459-467

In the version of this article initially published, Table 2 contains an error in the data of p-value.

On page 462, the table should be corrected as follows (marked in bold):

From:

Table 2 Mean Values of Each Patient-Reported Outcome Measure

PROsCategoryNo.Overall (n=355)Disease severityp-value

Moderate (n=330)*Severe (n=25)
HADSDepression3496.6±4.56.5±4.48.9±5.20.610
Anxiety3486.2±4.46.2±4.46.6±4.50.638
WPAI:UCAbsenteeism14929.1±36.927.3±35.854.1±43.50.102
Presenteeism§14337.8±31.436.8±30.362.2±39.60.037
Overall work impairmentII13045.5±32.744.1±31.970.7±37.80.048
Social activity impairment34446.4±31.245.2±31.061.2±31.00.014
IBDQBowel system34441.7±13.042.0±13.136.1±10.90.027
Emotional health34751.7±14.952.0±14.946.8±13.60.097
Systemic symptoms34720.5±6.820.7±6.817.0±6.00.009
Social function30923.2±7.722.8±7.918.0±6.80.003
Total score305137.3±38.8137.5±39.0117.9±33.20.002

Data are presented as the mean±SD.

PRO, patient-reported outcome; HADS, Hospital Anxiety and Depression Scale; WPAI, Work Productivity and Activity Impairment; UC, ulcerative colitis; IBDQ, Inflammatory Bowel Disease Questionnaire.

*Total Mayo score 6–10 points; Total Mayo score ≥11; Absenteeism: percentage of work time missed=(Q2/[Q2+Q4])×100; §Presenteeism: percentage of impairment while working=(Q5/10)×100; IIPercentage of overall work impairment=(Q2/(Q2+Q4)+[(1–(Q2/(Q2+Q4)))×(Q5/10)])×100; Percentage of social activity impairment=(Q6/10)×100; Q, questionnaire item.


To:

Table 2 Mean Values of Each Patient-Reported Outcome Measure

PROsCategoryNo.Overall (n=355)Disease severityp-value

Moderate (n=330)*Severe (n=25)
HADSDepression3496.6±4.56.5±4.48.9±5.20.024
Anxiety3486.2±4.46.2±4.46.6±4.50.638
WPAI:UCAbsenteeism14929.1±36.927.3±35.854.1±43.50.102
Presenteeism§14337.8±31.436.8±30.362.2±39.60.037
Overall work impairmentII13045.5±32.744.1±31.970.7±37.80.048
Social activity impairment34446.4±31.245.2±31.061.2±31.00.014
IBDQBowel system34441.7±13.042.0±13.136.1±10.90.027
Emotional health34751.7±14.952.0±14.946.8±13.60.097
Systemic symptoms34720.5±6.820.7±6.817.0±6.00.009
Social function30923.2±7.722.8±7.918.0±6.80.003
Total score305137.3±38.8137.5±39.0117.9±33.20.002

Data are presented as the mean±SD.

PRO, patient-reported outcome; HADS, Hospital Anxiety and Depression Scale; WPAI, Work Productivity and Activity Impairment; UC, ulcerative colitis; IBDQ, Inflammatory Bowel Disease Questionnaire.

*Total Mayo score 6–10 points; Total Mayo score ≥11; Absenteeism: percentage of work time missed=(Q2/[Q2+Q4])×100; §Presenteeism: percentage of impairment while working=(Q5/10)×100; IIPercentage of overall work impairment=(Q2/(Q2+Q4)+[(1–(Q2/(Q2+Q4)))×(Q5/10)])×100; Percentage of social activity impairment=(Q6/10)×100; Q, questionnaire item.


Gut and Liver

Vol.18 No.4
July, 2024

pISSN 1976-2283
eISSN 2005-1212

qrcode
qrcode

Share this article on :

  • line

Popular Keywords

Gut and LiverQR code Download
qr-code

Editorial Office